Promoter interactome of human embryonic stem cell-derived cardiomyocytes connects GWAS regions to cardiac gene networks.
Mun-Kit ChoyBiola M JavierreSimon G WilliamsStephanie L BarossYingjuan LiuSteven W WingettArtur AkbarovChris WallacePaula Freire-PritchettPeter J Rugg-GunnMikhail SpivakovPeter FraserBernard D KeavneyPublished in: Nature communications (2018)
Long-range chromosomal interactions bring distal regulatory elements and promoters together to regulate gene expression in biological processes. By performing promoter capture Hi-C (PCHi-C) on human embryonic stem cell-derived cardiomyocytes (hESC-CMs), we show that such promoter interactions are a key mechanism by which enhancers contact their target genes after hESC-CM differentiation from hESCs. We also show that the promoter interactome of hESC-CMs is associated with expression quantitative trait loci (eQTLs) in cardiac left ventricular tissue; captures the dynamic process of genome reorganisation after hESC-CM differentiation; overlaps genome-wide association study (GWAS) regions associated with heart rate; and identifies new candidate genes in such regions. These findings indicate that regulatory elements in hESC-CMs identified by our approach control gene expression involved in ventricular conduction and rhythm of the heart. The study of promoter interactions in other hESC-derived cell types may be of utility in functional investigation of GWAS-associated regions.
Keyphrases
- dna methylation
- genome wide
- gene expression
- genome wide association study
- left ventricular
- heart rate
- transcription factor
- copy number
- endothelial cells
- heart failure
- blood pressure
- heart rate variability
- induced pluripotent stem cells
- poor prognosis
- genome wide identification
- hypertrophic cardiomyopathy
- atrial fibrillation
- high glucose
- acute myocardial infarction
- mitral valve
- mass spectrometry
- high resolution
- stem cells
- single cell
- cell therapy
- mesenchymal stem cells
- cardiac resynchronization therapy
- coronary artery disease
- minimally invasive
- acute coronary syndrome
- binding protein
- transcatheter aortic valve replacement